GSK-2879552
Product Specifications
CAS Number
1401966-69-5
SKU
C03216-5mg
Target
LSD1
Applications
Epigenetics
Additionnal Information
GSK-2879552 is a selective and potent inhibitor of Lysine-specific demethylase 1 (LSD1, KDM1A), with the potential to treat Small cell lung cancer (SCLC) . It induces the expression of putative KDM1A target genes and demonstrates potent, predominantly cytostatic, antiproliferative activity in SCLC cell lines and tumor xenograft models.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CD9-HP2H3-25tests 25 Tests
PE-Labeled Human CD19 (20-291) Protein, His Tag (Site-specific conjugation)
Ask
View Details MBS1171116-01 0.02 mg (E-Coli)
Recombinant Campylobacter curvus Uracil-DNA glycosylase (ung)
Ask
View Details 
MBS1171116-02 0.1 mg (E-Coli)
Recombinant Campylobacter curvus Uracil-DNA glycosylase (ung)
Ask
View Details 
MBS1171116-03 0.02 mg (Yeast)
Recombinant Campylobacter curvus Uracil-DNA glycosylase (ung)
Ask
View Details MBS1171116-04 0.1 mg (Yeast)
Recombinant Campylobacter curvus Uracil-DNA glycosylase (ung)
Ask
View Details MBS1171116-05 0.02 mg (Baculovirus)
Recombinant Campylobacter curvus Uracil-DNA glycosylase (ung)
Ask
View Details